LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | JW-7-24-1 | 3.33 | uM | LJP6 | 3 | B20 | 72 | hr | 868 | 1833 | 3587 | 0.5110 | 0.4407 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 1 | B19 | 72 | hr | 868 | 849 | 3429 | 0.2475 | -0.0112 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 2 | B19 | 72 | hr | 868 | 841 | 3652 | 0.2303 | -0.0152 |
MDA-MB-231 | JW-7-24-1 | 10 | uM | LJP6 | 3 | B19 | 72 | hr | 868 | 940 | 3587 | 0.2620 | 0.0396 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 1 | I06 | 72 | hr | 868 | 719 | 3429 | 0.2096 | -0.0907 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 2 | I06 | 72 | hr | 868 | 771 | 3652 | 0.2111 | -0.0556 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP6 | 3 | I06 | 72 | hr | 868 | 841 | 3587 | 0.2344 | -0.0154 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 868 | 1762 | 3286 | 0.5362 | 0.4457 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 2 | D06 | 72 | hr | 868 | 1489 | 3505 | 0.4248 | 0.3073 |
MDA-MB-231 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 868 | 1694 | 3440 | 0.4924 | 0.4001 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 868 | 632 | 3429 | 0.1843 | -0.1480 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 868 | 639 | 3652 | 0.1750 | -0.1374 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 868 | 474 | 3587 | 0.1321 | -0.2559 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 868 | 686 | 3286 | 0.2088 | -0.1154 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 2 | D05 | 72 | hr | 868 | 811 | 3505 | 0.2314 | -0.0332 |
MDA-MB-231 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 868 | 713 | 3440 | 0.2073 | -0.0943 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 868 | 583 | 3429 | 0.1700 | -0.1820 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 868 | 568 | 3652 | 0.1555 | -0.1851 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 868 | 484 | 3587 | 0.1349 | -0.2483 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 868 | 517 | 3286 | 0.1573 | -0.2365 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 868 | 521 | 3505 | 0.1486 | -0.2240 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 868 | 451 | 3440 | 0.1311 | -0.2808 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 868 | 475 | 3429 | 0.1385 | -0.2623 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 868 | 477 | 3652 | 0.1306 | -0.2509 |
MDA-MB-231 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 868 | 572 | 3587 | 0.1595 | -0.1844 |